GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Bharat Parenterals Ltd

Bharat Parenterals Ltd Board Meeting To Consider Q1 FY27 Results

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 28 Jul 2026, 02:58 PM IST  ·  BSE ID: 47a7abd3-5236-4a48-bfed-38262a6daa23
View Original BSE Filing (PDF)
💡
In Simple Terms
The company is meeting to review its latest financial report card for the first quarter of the fiscal year.
🤖 AI Summary
  • Bharat Parenterals Ltd board meeting scheduled for August 5, 2026.
  • Purpose: consider and approve unaudited standalone and consolidated financial results.
  • Results are for the quarter ended June 30, 2026.
  • Trading window for designated persons closed from July 1, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should await the release of the financial results.
👤
Who Is Affected
All shareholders of Bharat Parenterals Ltd are affected as they will receive the company's financial performance update.
🔍
Management Signal
The scheduling of the board meeting signals management's adherence to regulatory timelines for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
August 5, 2026: Board meeting to approve Q1 FY27 results.
Announcement of Q1 FY27 unaudited financial results.
Disclosure of financial results on BSE and company website.
LOW RISK This is a routine notification of a board meeting for financial result approval.
💡 Investor Takeaway
Bharat Parenterals Ltd has announced a board meeting for August 5, 2026, to consider its unadjusted standalone and consolidated financial results for the quarter ending June 30, 2026.
❓ Frequently Asked Questions
When is the Bharat Parenterals Ltd board meeting scheduled?
The board meeting of Bharat Parenterals Ltd is scheduled for Wednesday, August 5, 2026.
What will be discussed at the Bharat Parenterals Ltd board meeting?
The board will consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
When did the trading window close for Bharat Parenterals Ltd?
The trading window for designated persons of Bharat Parenterals Ltd closed with effect from Wednesday, July 1, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.